Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Liver Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global liver disease treatment market reached a value of US$ 20.83 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 30.91 Billion by 2027 exhibiting a growth rate (CAGR) of 6.50% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

The liver is a vital organ of the human body that performs significant functions, such as storing vitamins and nutrients, removing harmful substances from the blood, and maintaining an adequate balance of chemicals in the body. Cancer, hepatitis, autoimmune diseases, and genetic disorders are some common liver diseases. These diseases are commonly caused by infections, genetics, obesity, diabetes, and immune system abnormalities. Some of the widely used therapeutic techniques for liver diseases include vaccines, chemotherapy, antiviral drugs, immunoglobulins, corticosteroids, and immunosuppressants. Liver disease treatment aids in the excretion of cholesterol and hormones, increases bile production and enzyme activation.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Liver Disease Treatment Market Trends:

The rising geriatric population, which is suspetible to various chronic ailments, including liver disease, across the globe is one of the prime factors driving the growth of the market. The changing dietary patterns and sedentary lifestyles are boosting the market growth. Additionally, the increasing prevalence of fatty liver disease due to high cholesterol, obesity, hypertension (high blood pressure), and diabetes is favoring the market growth. Moreover, various technological advancements, such as the development of the bioartificial liver, are providing an impetus to the market growth. It utilizes regenerated liver cells to replace liver functions and is widely used for acute liver failure patients. In line with this, the rapid adoption of antiviral drugs as they are safe and effective, assist in suppressing the hepatitis B virus, and help in reducing the risk of developing cirrhosis and hepatocellular carcinoma, is positively impacting the market growth. Apart from this, increasing research and development (R&D) activities, significant growth in the healthcare industry, and the implementation of various government initiatives to promote public health are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global liver disease treatment market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on treatment type, disease type and end user.

Breakup by Treatment Type:

  • Antiviral Drugs
  • Immunosuppressants
  • Vaccines
  • Immunoglobulins
  • Corticosteroids
  • Targeted Therapy
  • Chemotherapy
     

Breakup by Disease Type:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Hepatitis
  • Autoimmune Diseases
  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Cancer
  • Genetic Disorders
  • Others
     

Breakup by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Viatris Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
    Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Treatment Type, Disease Type, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited and Viatris Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Liver Disease Treatment Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Treatment Type
    6.1    Antiviral Drugs
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Immunosuppressants
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Vaccines
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Immunoglobulins
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Corticosteroids
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Targeted Therapy
        6.6.1 Market Trends
        6.6.2 Market Forecast
    6.7    Chemotherapy
        6.7.1 Market Trends
        6.7.2 Market Forecast
7    Market Breakup by Disease Type
    7.1    Hepatitis
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Autoimmune Diseases
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Non-alcoholic Fatty Liver Disease (NAFLD)
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Cancer
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Genetic Disorders
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Others
        7.6.1 Market Trends
        7.6.2 Market Forecast
8    Market Breakup by End User
    8.1    Hospitals
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Ambulatory Surgical Centers
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Others
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    AbbVie Inc.
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Astellas Pharma Inc.
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Bristol-Myers Squibb Company
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Eli Lilly and Company
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    Emergent BioSolutions Inc.
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    F. Hoffmann-La Roche AG
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
        14.3.8    Gilead Sciences Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    GlaxoSmithKline plc
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Merck & Co. Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Novartis AG
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Pfizer Inc.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis
        14.3.13    Sanofi S.A.
           14.3.13.1 Company Overview
           14.3.13.2 Product Portfolio
           14.3.13.3 Financials
           14.3.13.4 SWOT Analysis
        14.3.14    Takeda Pharmaceutical Company Limited
           14.3.14.1 Company Overview
           14.3.14.2 Product Portfolio
           14.3.14.3 Financials
           14.3.14.4 SWOT Analysis
        14.3.15    Viatris Inc.
           14.3.15.1 Company Overview
           14.3.15.2 Product Portfolio
           14.3.15.3 Financials

List of Figures

Figure 1: Global: Liver Disease Treatment Market: Major Drivers and Challenges
Figure 2: Global: Liver Disease Treatment Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Liver Disease Treatment Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Liver Disease Treatment Market: Breakup by Treatment Type (in %), 2021
Figure 5: Global: Liver Disease Treatment Market: Breakup by Disease Type (in %), 2021
Figure 6: Global: Liver Disease Treatment Market: Breakup by End User (in %), 2021
Figure 7: Global: Liver Disease Treatment Market: Breakup by Region (in %), 2021
Figure 8: Global: Liver Disease Treatment (Antiviral Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Liver Disease Treatment (Antiviral Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Liver Disease Treatment (Immunosuppressants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Liver Disease Treatment (Immunosuppressants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Liver Disease Treatment (Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Liver Disease Treatment (Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Liver Disease Treatment (Immunoglobulins) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Liver Disease Treatment (Immunoglobulins) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Liver Disease Treatment (Corticosteroids) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Liver Disease Treatment (Corticosteroids) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Liver Disease Treatment (Targeted Therapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Liver Disease Treatment (Targeted Therapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Liver Disease Treatment (Chemotherapy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Liver Disease Treatment (Chemotherapy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Liver Disease Treatment (Hepatitis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Liver Disease Treatment (Hepatitis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Liver Disease Treatment (Autoimmune Diseases) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Liver Disease Treatment (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Liver Disease Treatment (Non-alcoholic Fatty Liver Disease (NAFLD)) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Liver Disease Treatment (Non-alcoholic Fatty Liver Disease (NAFLD)) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Liver Disease Treatment (Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Liver Disease Treatment (Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Liver Disease Treatment (Genetic Disorders) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Liver Disease Treatment (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Liver Disease Treatment (Other Disease Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Liver Disease Treatment (Other Disease Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Liver Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Liver Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Liver Disease Treatment (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Liver Disease Treatment (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Liver Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Liver Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: North America: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: North America: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: United States: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: United States: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Canada: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Canada: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Asia-Pacific: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Asia-Pacific: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: China: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: China: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Japan: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Japan: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: India: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: India: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: South Korea: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: South Korea: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Australia: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Australia: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Indonesia: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Indonesia: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Europe: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Europe: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Germany: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Germany: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: France: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: France: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: United Kingdom: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: United Kingdom: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Italy: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Italy: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Spain: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Spain: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Russia: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Russia: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Latin America: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Latin America: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Brazil: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Brazil: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Mexico: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Mexico: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Others: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Others: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Middle East and Africa: Liver Disease Treatment Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Middle East and Africa: Liver Disease Treatment Market: Breakup by Country (in %), 2021
Figure 88: Middle East and Africa: Liver Disease Treatment Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Global: Liver Disease Treatment Industry: SWOT Analysis
Figure 90: Global: Liver Disease Treatment Industry: Value Chain Analysis
Figure 91: Global: Liver Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Liver Disease Treatment Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Liver Disease Treatment Market Forecast: Breakup by Treatment Type (in Million US$), 2022-2027
Table 3: Global: Liver Disease Treatment Market Forecast: Breakup by Disease Type (in Million US$), 2022-2027
Table 4: Global: Liver Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Liver Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Liver Disease Treatment Market: Competitive Structure
Table 7: Global: Liver Disease Treatment Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global liver disease treatment market was valued at US$ 20.83 Billion in 2021.

We expect the global liver disease treatment market to exhibit a CAGR of 6.50% during 2022-2027.

The rising geriatric population, along with the increasing prevalence of fatty liver disease, owing to the
high cholesterol level, obesity, hypertension, etc., is primarily driving the global liver disease treatment
market.

The sudden outbreak of the COVID-19 pandemic had led to postponement of numerous elective
treatment procedures to reduce the risk of coronavirus infection upon hospital visits or interaction with
healthcare professionals and medical equipment.

Based on the treatment type, the global liver disease treatment market can be segmented into antiviral
drugs, immunosuppressants, vaccines, immunoglobulins, corticosteroids, targeted therapy, and
chemotherapy. Currently, antiviral drugs hold the majority of the total market share.

Based on the disease type, the global liver disease treatment market has been divided into hepatitis,
autoimmune diseases, Non-alcoholic Fatty Liver Disease (NAFLD), cancer, genetic disorders, and others.
Among these, hepatitis exhibits a clear dominance in the market.

Based on the end user, the global liver disease treatment market can be categorized into hospitals,
ambulatory surgical centers, and others. Currently, hospitals account for the largest market share.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global liver disease treatment market include Abbott Laboratories,
AbbVie Inc., Astellas Pharma Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Emergent
BioSolutions Inc., F. Hoffmann-La Roche AG, Gilead Sciences Inc., GlaxoSmithKline plc, Merck & Co. Inc.,
Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, and Viatris Inc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links